CA2170485A1 - Compositions renfermant un sel d'acide propionique d'amino-acide, agents anti-inflammatoires non steroidiques utilises avec la cafeine - Google Patents
Compositions renfermant un sel d'acide propionique d'amino-acide, agents anti-inflammatoires non steroidiques utilises avec la cafeineInfo
- Publication number
- CA2170485A1 CA2170485A1 CA2170485A CA2170485A CA2170485A1 CA 2170485 A1 CA2170485 A1 CA 2170485A1 CA 2170485 A CA2170485 A CA 2170485A CA 2170485 A CA2170485 A CA 2170485A CA 2170485 A1 CA2170485 A1 CA 2170485A1
- Authority
- CA
- Canada
- Prior art keywords
- caffeine
- amino acid
- inflammatory agents
- steroidal anti
- compositions containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 title abstract 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- -1 Amino Acid Salt Chemical class 0.000 title abstract 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001948 caffeine Drugs 0.000 title abstract 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 title abstract 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 title abstract 2
- 235000019260 propionic acid Nutrition 0.000 title abstract 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 title abstract 2
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11738993A | 1993-09-07 | 1993-09-07 | |
| US117,389 | 1993-09-07 | ||
| PCT/US1994/009582 WO1995007079A1 (fr) | 1993-09-07 | 1994-08-24 | Compositions contenant un sel d'acide amine d'agents anti-inflammatoires non steroidiens a base d'acide propionique et de la cafeine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2170485A1 true CA2170485A1 (fr) | 1995-03-16 |
| CA2170485C CA2170485C (fr) | 2000-11-07 |
Family
ID=22372657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002170485A Expired - Fee Related CA2170485C (fr) | 1993-09-07 | 1994-08-24 | Compositions renfermant un sel d'acide propionique d'amino-acide, agents anti-inflammatoires non steroidiques utilises avec la cafeine |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0717624A1 (fr) |
| JP (1) | JPH09502202A (fr) |
| AU (1) | AU7604194A (fr) |
| BR (1) | BR9407415A (fr) |
| CA (1) | CA2170485C (fr) |
| WO (1) | WO1995007079A1 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6017887A (en) * | 1995-01-06 | 2000-01-25 | Sibia Neurosciences, Inc. | Peptide, peptide analog and amino acid analog protease inhibitors |
| US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
| PL330145A1 (en) * | 1996-05-20 | 1999-04-26 | Searle & Co | Pharmaceutic preparations containing sodium and potassum oxaprosin salt as well as that formed from tris |
| JP2002510336A (ja) | 1998-04-11 | 2002-04-02 | エレカッパ・ユウロテラピッチ・ソシエタ・ペル・アチオニ | 水溶性ケトプロフェン塩を含有する薬学的調製物及びその使用方法 |
| NZ508490A (en) | 1998-07-09 | 2003-08-29 | Warner Lambert Co | Use of a combination of a GABA analog and caffeine as an analgesic |
| US6211246B1 (en) * | 1999-06-10 | 2001-04-03 | Mcneil-Ppc, Inc. | Rapidly absorbed liquid compositions |
| US20040115290A1 (en) | 2001-06-20 | 2004-06-17 | Tripp Matthew L. | Modulation of inflammation by hops fractions and derivatives |
| US8158160B2 (en) | 2001-11-13 | 2012-04-17 | Eric Hauser Kuhrts | Anti-inflammatory cyclooxygenase inhibitors |
| US7166641B2 (en) * | 2002-10-02 | 2007-01-23 | Yung Shin Pharmaceutical Industrial Co., Ltd. | Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same |
| US7863287B2 (en) * | 2002-12-18 | 2011-01-04 | Wyeth Llc | Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
| US9149474B2 (en) | 2011-11-23 | 2015-10-06 | Michael Leighton | Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant |
| US9629847B2 (en) | 2011-11-23 | 2017-04-25 | Michael Leighton | Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant |
| EP3406239B1 (fr) * | 2017-05-22 | 2021-10-20 | Epifarma Srl | Solutions de sel de lysine de kétoprofène agréables au goût |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4420483A (en) * | 1982-07-22 | 1983-12-13 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same |
| DE3328401A1 (de) * | 1983-08-05 | 1985-02-21 | Merckle GmbH, 7902 Blaubeuren | Injizierbare loesung zur behandlung von entzuendungen |
| WO1991006295A1 (fr) * | 1989-11-06 | 1991-05-16 | Sepracor, Inc. | Composition analgesique contenant du s(+) flurbiprofene optiquement pur |
| US4994604A (en) * | 1990-01-10 | 1991-02-19 | Merck & Co., Inc. | Formation and resolution of ibuprofen lysinate |
| EP0663819A4 (fr) * | 1992-09-29 | 1998-05-27 | Merck & Co Inc | Association d'ibuprofene et de cafeine. |
| EP0674517A1 (fr) * | 1992-12-21 | 1995-10-04 | The Procter & Gamble Company | Compositions contenant de la cafeine et s(+)-ibuprofene ou s(+)-flurbiprofene ou s(+)-cetoprofene |
| AU5995094A (en) * | 1993-01-29 | 1994-08-15 | Merck & Co., Inc. | Ciclobenzaprine-caffeine combination as a muscle relaxant |
-
1994
- 1994-08-24 AU AU76041/94A patent/AU7604194A/en not_active Abandoned
- 1994-08-24 JP JP7508696A patent/JPH09502202A/ja active Pending
- 1994-08-24 EP EP94926021A patent/EP0717624A1/fr not_active Withdrawn
- 1994-08-24 BR BR9407415A patent/BR9407415A/pt not_active Application Discontinuation
- 1994-08-24 WO PCT/US1994/009582 patent/WO1995007079A1/fr not_active Application Discontinuation
- 1994-08-24 CA CA002170485A patent/CA2170485C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH09502202A (ja) | 1997-03-04 |
| CA2170485C (fr) | 2000-11-07 |
| BR9407415A (pt) | 1996-11-12 |
| WO1995007079A1 (fr) | 1995-03-16 |
| AU7604194A (en) | 1995-03-27 |
| EP0717624A1 (fr) | 1996-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2125644A1 (fr) | Compositions pharmaceutiques contenant des sels de l'acide s(+)-2-(4-isobutylphenyl)propionique et d'acides amines basiques | |
| CA2170485A1 (fr) | Compositions renfermant un sel d'acide propionique d'amino-acide, agents anti-inflammatoires non steroidiques utilises avec la cafeine | |
| IE862404L (en) | Hydroxamic acid derivatives | |
| GB2260079B (en) | Pharmaceutical composition containing felbinac | |
| RU93047799A (ru) | Композиции, содержащие ретиноевые кислоты и токоферол | |
| IL76932A (en) | Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen | |
| MD921G2 (ro) | Derivaţi arilpropionici, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor | |
| GR3020832T3 (en) | Topical composition containing ketoprofen lysinate | |
| NZ215676A (en) | Topical pharmaceutical compositions with vehicle containing hyaluronic acid derivatives; preparation or hyaluronic acid salts | |
| AU5916998A (en) | Non-irritating composition for treating acne and other skin conditions | |
| CA2108903A1 (fr) | Composes dibenzoxazepine substitues, compositions pharmaceutiques et methodes d'utilisation | |
| AU4603293A (en) | Antiperspirant actives and compositions | |
| EP0208519A3 (fr) | Composition solubilisée d'un agent pharmaceutique peu soluble | |
| AU2101492A (en) | Methanoanthracenes having antidopaminergic activity | |
| CA2202397A1 (fr) | Compositions comprenant de l'acide dichloroacetique tamponne au carbonate/bicarbonate et procedes de traitement de troubles metaboliques et cardiovasculaires | |
| AU2101592A (en) | Piperidine derivatives | |
| AU3386589A (en) | Acid addition salts of tauro- and glycochlolic acid and their use in pharmaceutical compositions | |
| IL90056A0 (en) | Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives | |
| IE832273L (en) | 7-substituted-3-vinyl-3-cephem compounds | |
| WO1991018606A3 (fr) | Analgesiques actifs par voie orale ne creant pas d'accoutumance | |
| CA2279184A1 (fr) | Compositions pharmaceutiques contenant de l'ibuprofene et de la domperidone pour le traitement de la migraine | |
| WO1992017065A3 (fr) | Procede d'inhibition de la fibrose | |
| AU7096096A (en) | Indole derivatives and medical application thereof | |
| CA2038025A1 (fr) | Derives de l'alkylenedioxybenzene optiquement actifs et leur utilisation a des fins therapeutiques | |
| GB2258397A (en) | Pharmaceutical compositions containing amethocaine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |